The FINANCIAL -- Pfizer Inc. and BioNTech SE announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateral efforts to address the surge of infection in many parts of the world and to help end the pandemic. The government will, in turn, donate the Pfizer-BioNTech vaccine doses to low- and lower middle-income countries and organizations that support them, Pfizer notes. …
Read More »The FINANCIAL -- Pfizer Inc. and BioNTech SE announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateral efforts to address the surge of infection in…
You might be interested in
The FINANCIAL — People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have…
Epidemiologist explains how to stay on guard against subvariants, noting role of protective measures in transition to new pandemic phase…
A new study measuring the impact of COVID-19 on the wellbeing and mental health of adolescents has found that the…